Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2015 Jan 30;10(1):e0117056. doi: 10.1371/journal.pone.0117056

A Co-Culture System with an Organotypic Lung Slice and an Immortal Alveolar Macrophage Cell Line to Quantify Silica-Induced Inflammation

Falk Hofmann 1, Robert Bläsche 1, Michael Kasper 1, Kathrin Barth 1,*
Editor: Min Wu2
PMCID: PMC4312074  PMID: 25635824

Abstract

There is growing evidence that amorphous silica nanoparticles cause toxic effects on lung cells in vivo as well as in vitro and induce inflammatory processes. The phagocytosis of silica by alveolar macrophages potentiates these effects. To understand the underlying molecular mechanisms of silica toxicity, we applied a co-culture system including the immortal alveolar epithelial mouse cell line E10 and the macrophage cell line AMJ2-C11. In parallel we exposed precision-cut lung slices (lacking any blood cells as well as residual alveolar macrophages) of wild type and P2rx7−/− mice with or without AMJ2-C11 cells to silica nanoparticles. Exposure of E10 cells as well as slices of wild type mice resulted in an increase of typical alveolar epithelial type 1 cell proteins like T1α, caveolin-1 and -2 and PKC-β1, whereas the co-culture with AMJ2-C11 showed mostly a slightly lesser increase of these proteins. In P2rx7−/− mice most of these proteins were slightly decreased. ELISA analysis of the supernatant of wild type and P2rx7−/− mice precision-cut lung slices showed decreased amounts of IL-6 and TNF-α when incubated with nano-silica. Our findings indicate that alveolar macrophages influence the early inflammation of the lung and also that cell damaging reagents e.g. silica have a smaller impact on P2rx7−/− mice than on wild type mice. The co-culture system with an organotypic lung slice is a useful tool to study the role of alveolar macrophages during lung injury at the organoid level.

Introduction

Silicon dioxid (silica, SiO2) is one of the most common elements on earth, but inhalation of silica can lead to an injury of the lung, prolonged inhalation can even lead to chronic inflammation and fibrosis due to deposition of silica particles in the lung. The typical lung reaction induced by chronic inhalation of crystalline silica is silicosis, a generally progressive fibrotic lung disease (pneumoconiosis), exemplified by the development of silicotic nodules composed of silica particles surrounded by whorled collagen in concentric layers, with macrophages, lymphocytes, and fibroblasts in the periphery. The proliferation of lung epithelial cells is a prominent feature of lung tissue response following silica-induced lung injury and alveolar macrophages are recognized as a major contributing cell to the lung inflammatory process.

The growing abundance and industrial applications of nanotechnology has resulted in a recent shift of toxicological research towards nanoparticles. The particles seem to affect epithelial cells, fibroblasts and lung macrophages [14]. Ultrafine particles (< 0,1 µm) cause a greater inflammatory response than do fine particles (< 2,5 µm) per given mass [57]. Cytotoxicity of silica may be caused by penetration of the cytoplasm; whereas nano-silica up to ca. 100 nm can even penetrate into nuclear regions [810], where the silica particles lead to an inflammatory response through to generation of reactive oxygen species (ROS) [9, 11, 12]. The cytotoxicity of silica seems to be dose- time- and size-dependent [1116].

The acute injury of the lung is characterized by an unbalanced quantity or quality of the inflammatory response to epithelial or endothelial injury leading to inflammation, cellular damage, apoptosis or necrosis of cells of the alveolar-capillary barrier [17]. Dysregulated resolution and repair can result in an excessive fibroproliferation with development of pulmonary fibrosis [18]. To model the early inflammatory stage of both diseases silica can be used due to its generation of a chronic inflammation as reviewed in [19].

One protein intensively studied in context with pulmonary fibrosis and lung inflammation is caveolin-1 (Cav-1), which is abundantly expressed in lung epithelia, endothelia, and fibroblasts [20]. Cav-1 contributes both to endothelial and epithelial pathologies: Endothelial Cav-1 regulates microvascular permeability by controlling caveolar transcytosis e.g. albumin and inhibits the endothelial nitric oxide synthaseactivity [21]. Epithelial Cav-1 controls a common pathway of apoptosis by regulating survivin [2224]. Further Cav-1 promotes apoptosis in the bleomycin fibrosis model and plays a role in epithelial cell growth arrest and senescence [2529]. Closely related to Cav-1 in alveolar epithelial cells is a purinergic receptor, P2X7R, due to its molecular interaction and its occurrence in the lipid raft/caveolae fraction. P2X7 receptors are selectively localized in alveolar epithelial type I cells (AEC I) and are thought to play a role in fluid haemostasis [30]. Their involvement in lung inflammation and tissue regeneration needs to be further explored.

Riteau et al. [31] demonstrated that phagocytosis of silica particles induces the active release of ATP by human peritoneal macrophages and purinergic signaling leading in inflammasome activation.

Moncao-Ribeiro et al. [32] showed in vitro silica-induced IL-1β secretion in macrophages (AMJ2-C11). It was also demonstrated that pre-incubation with a P2X7 receptor specific inhibitor completely inhibited silica-induced IL-1β secretion. The alveolar macrophages treated with silica and P2X7 receptor inhibitor have shown decreased silica phagocytosis. These results support the findings of Wiley and Gu [33] who observed that P2X7 receptor expressed in phagocytic cells augments the engulfment of latex beads and bacteria.

We used a co-culture system consisting of alveolar epithelial cells (E10) and an immortal macrophage cell line AMJ2-C11 as an approach to reflect the interactions between different cell types in the lung after exposure to nanoparticles. In parallel we included a new co-culture system with an organotypic lung slice (precision-cut lung slices, PCLS) and immortal alveolar macrophage cell line AMJ2-C11 to quantify silica-induced inflammation.

The aim of this study was to obtain basic data on the biological effects of the silica nanoparticle—macrophage interaction on epithelial cells.

Animals, Material and Methods

Ethics Statement

All animal experiments were approved by the ethics committee of the Dresden University of Technology and the license for removal of organs was provided by the Landesdirektion Dresden (file no. 24–9168.24–1/2007–26; file no. 24–9168.24–1/2010–11).

Mice

For our experiments we used wild type (C57BL/6; Charles River, Wilmington, MA, USA) and P2rx7−/−mice (B6.129P2-P2rx7tm1Gab/J; Pfizer, New York City, NY, USA) [34]. Our animals were housed at the Animal Care Facility at the Medical Faculty “Carl Gustav Carus” of Dresden, University of Technology. The mice always had free access to standard chow and water. All performed procedures were in accordance with the Dresden University of Technology Animal Care and Use Committee Guidelines. We examined lung tissues from male and female mice (8–18 weeks) for our experiments.

Silica

We used nano-silica from Sigma Aldrich (St. Louis, MO, USA). Following specifications of the nanoparticles were provided by the supplier: spherical, porous, particle size 5–15 nm (measured with transmission electron microscopy).

Concentration of silica in the experiments is given as mass per area for cultures with adherent cells due to the tendency of silica to sediment and as mass per volume in non-adherent culture because of the agitation in a roller system.

Cell lines and cell culture

As a model for the alveolar epithelium we used a spontaneous immortalized lung non-tumor cell line of the mouse (E10 cells; kindly provided by M. Williams, Pulmonary Center, Boston University School of Medicine, Boston, MA, USA) as previously reported [35]. E10 cells were cultured in DMEM/Ham’s F12 medium from Gibco (ThermoFisher Scientific, Waltham, MA, USA), supplemented with 5% (v/v) fetal bovine serum (PAN Biotech GmbH, Aidenbach, Germany) and 2.5 mM L-glutamine (Merck, Darmstadt, Germany). E10 cells were grown at 37°C in a 5% CO2 atmosphere up to a confluence of approximately 60–80%. They were seeded at a density of 2x104 cells/ml and passaged three times per week up to 25 passages.

Secondly we used AMJ2-C11 alveolar macrophages infected with the J2 retrovirus carrying the v-raf and v-myc oncogens (ATCC, Wesel, Germany) [36].

AMJ2-C11 cells were cultivated with DMEM high-glucose medium (Merck) supplemented with 5% (v/v) fetal bovine serum, 1% (v/v) sodium pyruvate, 2% (v/v) L-glutamine, 2% (v/v) NaHCO3 and 5 mM HEPES (all from Merck). They were grown at 37°C in a 5% CO2 atmosphere. They were seeded at a density of 2x105 cells/ml and passaged two times per week up to 40 passages.

As experimental set-ups we used (i) a E10-mono-culture and (ii) a co-culture of E10 and AMJ2-C11. The cells were treated with 50, 100 or 200 µg nano-silica per cm2 ground area of the flasks by adding the nano-silica to the medium, because of the adherent character of this experimental set-up.

Precision-cut lung slices and tissue culture

Following the preparation procedure of precision-cut lung slices (PCLS) published by Held et al.[37] and recently described by Ebeling et al.[38] tissue preparation was done with several modifications. Wild type and P2rx7−/− mice were anesthetized with an overdose of 5% (w/v) thiopental (Thiopental 0.5 g, Inresa, Freiburg, Germany) and exsanguinated by cutting the right renal artery. The chest wall was opened and the lungs were perfused with 10 ml PBS at RT through the right ventricle. Subsequently the trachea was cannulated with a 20-gauge catheter (Saf-T-Intima with Y adapter, BD Biosciences, San Diego, CA, USA) and the lungs were filled with 1% (w/v) low-melting agarose (Sigma-Aldrich) solved in PBS at 37°C in situ. For agarose solification the mouse was cooled with ice for 15 minutes at 4°C. Next, solidified lungs were removed and separated into the different lobes. Each lobe was embedded in 3% (w/v) prewarmed agarose at 42°C. For gelling, agarose was cooled with ice at 4°C for 15 minutes. Afterwards each lobe was cut with Krumdieck tissue slicer (Alabama Research and Development, Munford, AL, USA) into 500 μm thick slices using DMEM/F12 medium with 15 mM HEPES and 2.5 mM L-glutamine cooled down to 4°C. Then tissue slices were transferred into cell culture plates containing above-mentioned medium including 1% (v/v) pen/strep (Merck) and 0.5% (v/v) fetal bovine serum at 37°C. During the following 3 hours medium was changed every 30 minutes. For add-on tissue culture five lung slices each were transferred into a 20 ml glass vial (Scintillation Vial, KG-33 Borosilica Glass, VWR International, Radnor, PA, USA) containing 3 ml medium for culture without macrophages and 5 ml medium for co-culture with macrophages. For treatment with nano-silica medium was completed with 1600 µg/ml nano-silica, because of the non-adherent character of this experimental set-up. Glasses were closed with Filter Easy Caps 25 cm2 (ThermoFisher Scientific). The vials were put in a roller system (Stuart Rotator SB3, Bibby Scientific, Staffordshire, United Kingdom) rotating at 5 rpm in a 5% CO2 atmosphere at 37°C. After 72 hours incubation the lung slices were homogenized for Western Blotting or embedded in paraffin for immunostaining. The supernatant was collected for ELISA analysis.

Western Blot analysis, conventional histology and immunohistochemistry

Methods were performed with minor modifications as previously described byEbeling et al.[38]. We collected the lung slices and either fixed them in 4% (v/v) buffered formalin, followed by paraffin embedding and sectioning or homogenized them for Western Blot analysis. E10 cells were harvested using a probing buffer (0,187 M Tris pH 6, 9; 6% SDS; 30% glycerine; 10 mM DTT and Bromophenolblue 40 mg/10 ml) for cell lysis and later loaded on a SDS-PAGE. AMJ2-C11 were separated from E10 by rinsing twice with PBS (Merck).

For Western Blot analysis total protein concentrations of homogenized lung slices were measured by Pierce BCA Protein Assay Kit (ThermoFisher Scientific) and total protein concentrations of E10 cell lysates were determined with the amidoschwarz protein assay earlier described by Dieckmann-Schuppert and Schnittler [39]. SDS-PAGE and Western Blot were performed as accurately described by Linge et al. [40]. After blocking with TBS-T buffer (137 mM NaCl,; 2, 7 mM KCl; 20 mM Tris-HCl pH 7.4; 0,05% Tween20) including 5% (w/v) dried non-fat powdered milk (Carl Roth GmbH, Karlsruhe, Germany) blots were incubated with the primary antibodies listed in Table 1. We used following secondary antibodies: donkey anti-rabbit IgG, HRP-linked F(ab)2 fragment (GE Healthcare, Chalfont St Giles, Buckinghamshire, United Kingdom), horse anti-mouse IgG, HRP-linked antibody (Cell Signaling, Danvers, MA, USA), and goat anti-Syrian hamster IgG-HRP (Santa Cruz, Dallas, TX, USA). Chemiluminescent signal was detected with Image Reader LAS-3000 (Fujifilm, Tokio, Japan) by following manufacture’s guidelines of Immobilon Western Chemiluminescent HRP Substrate (Merck). Quantification was done with ImageJ 1.43u free software (Wayne Rasband, National Institutes of Health, Bethesda, MD, USA) and each lane was normalized to corresponding γ-Tubulin (γ-Tub).

Table 1. Primary antibodies used for Western Blot (WB) and immunohistochemistry (IHC).

Antibody Dilution used for Host Type Supplier
WB IHC
anti-γ-Tubulin clone GTU-88 1:500 - Mouse Monoclonal Sigma-Aldrich (St. Louis, MO, USA)
anti-caspase-3 (Asp175) - 1:50 Rabbit Polyclonal Cell Signaling (Danvers, MA, USA)
anti-caveolin 1 (clone 2297) 1:500 - Mouse Monoclonal BD Biosciences (Franklin Lakes, NJ, USA)
anti-caveolin 1 (D46G3) - 1:1600 Rabbit Monoclonal Cell Signaling (Danvers, MA, USA)
anti-caveolin 2 (clone 65) 1:500 1:400 Mouse Monoclonal BD Biosciences (Franklin Lakes, NJ, USA)
anti-P2X7R 1:500 - Rabbit Polyclonal Alomone Labs (Jerusalem, Israel)
anti-PKC-β1 1:400 1:200 Rabbit Polyclonal Santa Cruz (Dallas, TX, USA)
anti-Podoplanin (T1α) - 1:100 Hamster Monoclonal Kindly provided by M. Williams (Boston, MA, USA)
anti-Podoplanin (T1α) (8.1.1) 1:1000 - Hamster Monoclonal Santa Cruz (Dallas, TX, USA)

Conventional histology was done as described by Ebeling et al. [38] and Sirius Red staining of collagen and reticulin fibers was made as previously described by Kasper et al. [41]. Immunohistochemistry was performed according to Kasper and Fehrenbach [42] as described in detail by Ebeling et al. [38].

ELISA

Cytokine release was measured using an ELISA against IL-6 and TNF-α. The supernatant of following experiments was used for analyses: (i) PCLS of wild type mice with and (ii) without macrophages as well as (iii) PCLS of P2rx7−/−mice with and (iv) without macrophages. We used an ELISA kit from Affymetrix (Ready-SET-Go!—Santa Clara, CA, USA) following manufacture’s guidelines.

FACS

To evaluate the viability of AMJ2-C11 as they interfere with nano-silica we used a calcein / Annexin V staining for FACS analysis. Living cells take up the non-fluorescent calcein-AM (ThermoFisher Scientific) and hydrolyses it to calcein, a strong fluorescent compound, by intracellular esterases. Dead cells were stained with Annexin V (BD Biosciences), a cellular protein binding phosphatidylserine and phosphatidylethenolamine which are only surfaced on the cell during apoptotic cell death.

Cells were collected and centrifuged, thereafter the medium was discarded. We rinsed the cells twice with PBS to eliminate medium remains, discarded the supernatant each time and stained with 100µl Annexin Binding buffer containing 1:4000 Calcein in DMSO and 1:200 Annexin V in Annexin Binding Buffer. After 15 minutes of incubation in darkness, 400 µl Annexin Binding buffer were added to each probe. After vortexing analysis was performed using FACSCalibur (BD Biosciences) following manufacture’s guidelines. Measurement was conducted with CellQuest 3.3 (BD Biosciences) till 10.000 cells were counted.

Statistical analysis

Results are presented as means ± standard error of the mean (SEM). Statistical analysis was performed pretesting for a Gaussian distribution with Shapiro-Wilk-Test followed by a two-tailed student t test. Statistical analysis was done with GraphPad Prism 5.03 software (GraphPad Software, San Diego, CA, USA). The following significance levels were used:

* p ≤ 0.05; ** p ≤ 0.01. A minimum of three independent experiments were done.

Results

Treatment of PCLS with nano-silica as a model for early lung inflammation

First we assessed three markers for cell damage, apoptosis and repair in precision-cut lung slices: caspase 3 (Cc3), T1α and collagen deposition. T1α is an AEC I specific protein and early marker of lung injury [43]. Second we tested four proteins of AEC I involved in membrane integrity and cell signaling pathways: Cav-1 and caveolin-2 (Cav-2), two membrane proteins forming caveolae important for cell signaling, P2X7R, an AEC I specific purinergic receptor and protein kinase C-β1 (PKC-β1), a downstream signaling protein of P2X-receptors [44].

We found an increase in the protein level of Cc3 (Fig. 1A) and T1α (Fig. 1B) indicated by immunohistochemical staining, but no differences in collagen deposition with Sirius Red staining (Fig. 1C) after incubation of the lung slices with 1600 µg/ml nano-silica for 72 hours. Immunocytochemical evaluation of T1α showed a protein level increase to 120% (Fig. 2A).

Figure 1. Evaluation of cell damage by nano-silica and macrophages in the PCLS of wild type mice.

Figure 1

Immunohistochemical staining of Cc3 (A) and T1α (B), as well as Sirius Red staining (C) of representative untreated lung slices, slices treated with 1600 µg/ml silica and slices treated with 1600 µg/ml silica and co-cultured with AMJ2-C11 macrophages after 72 hours. Scale bar = 50 µm.

Figure 2. Protein content of T1α in the PCLS of wild type mice and the alveolar epithelial cell line E10.

Figure 2

Immunoblots of PCLS and E10 experiments without (A) and with AMJ2-C11 macrophages (B). For PCLS the concentration of nano-silica was 1600 µg/ml and for E10 experiments nano-silica concentrations ranging from 50 to 200 µg/cm2 flask area were used. Data of each silica group was normalized to the control. Incubation time of PCLS was 72 hours and for E10 experiments 48 hours. γ-Tub is the loading control, n = 6–7.

Western Blot analysis of the AEC I proteins showed an increase to 164% for Cav-1 (Fig. 3A), 118% for Cav-2 (Fig. 4A) and 110% for PKC-β1 (Fig. 5A), whereas P2X7R decreased to 94% (Fig. 6A).

Figure 3. Cav-1 immunohistochemical staining and protein content of wild type mice PCLS and E10.

Figure 3

(A) Immunohistochemical staining of Cav-1 of representative untreated lung slices, slices treated with 1600 µg/ml silica and slices treated with 1600 µg/ml silica and co-cultured with AMJ2-C11 macrophages as well as Western Blot analysis of PCLS. Data was normalized to the control. PCLS was incubated for 72 hours. (B) Immunoblots of E10 experiments without and with AMJ2-C11 macrophages. For E10 experiments nano-silica concentrations ranging from 50 to 200 µg/cm2 flask area and an incubation time of 48 hours were used. Each silica concentration was normalized to the control. γ-Tub is the loading control, n = 6–7. Scale bar = 50 µm.

Figure 4. Cav-2 immunohistochemical staining and protein content of wild type mice PCLS and E10.

Figure 4

(A) Immunohistochemical staining of Cav-2 of representative untreated lung slices, slices treated with 1600 µg/ml silica and slices treated with 1600 µg/ml silica and co-cultured with AMJ2-C11 macrophages as well as Western Blot analysis of PCLS. Data was normalized to the control. PCLS was incubated for 72 hours. (B) Immunoblots of E10 experiments without and with AMJ2-C11 macrophages. For E10 experiments nano-silica concentrations ranging from 50 to 200 µg/cm2 flask area and an incubation time of 48 hours were used. Each silica concentration was normalized to the control. γ-Tub is the loading control, n = 6–7. Scale bar = 50 µm.

Figure 5. PKC-β1 immunohistochemical staining and protein content of wild type mice PCLS and E10.

Figure 5

(A) Immunohistochemical staining of PKC-β1 of representative untreated lung slices, slices treated with 1600 µg/ml silica and slices treated with 1600 µg/ml silica and co-cultured with AMJ2-C11 macrophages as well as Western Blot analysis of PCLS. Data was normalized to the control. PCLS was incubated for 72 hours. (B) Immunoblots of E10 experiments without and with AMJ2-C11 macrophages. For E10 experiments nano-silica concentrations ranging from 50 to 200 µg/cm2 flask area and an incubation time of 48 hours were used. Each silica concentration was normalized to the control. γ-Tub is the loading control, n = 6–7. Scale bar = 50 µm.

Figure 6. Protein content of P2X7R in the PCLS of wild type mice and E10.

Figure 6

Immunoblots of PCLS and E10 experiments without (A) and with AMJ2-C11 macrophages (B) after 72 hours incubation. For PCLS the concentration of nano-silica was 1600 µg/ml and for E10 experiments nano-silica concentrations ranging from 50 to 200 µg/cm2 flask area and an incubation time of 48 hours were used. Each silica concentration was normalized to the control. γ-Tub is the loading control, n = 6–7.

Effects of nano-silica on the cell line E10

To verify the results from the PCLS we analysed the influence of nano-silica on the alveolar epithelial cell line E10. Also we determined the dose-dependency of cytotoxicity by using 3 concentrations of nano-silica: 50, 100 and 200 µg/cm2.

The treatment with nano-silica showed a high increase of the T1α protein level ranging from 156% at a nano-silica concentration of 50 μg/cm2 up to 250% at 200 μg/cm2 (Fig. 2A). Protein level of Cav-1 showed a decrease to 85% with 50 μg/cm2 nano-silica, but with an increasing concentration of nano-silica (cnSi) Cav-1 protein level also increased up to 117% (Fig. 3B). Protein content of Cav-2 also increased ranging from 115% up to 157% (Fig. 4B). The protein level of PKC-β1 rose with raising cnSi from 107% up to 145% (Fig. 5B). P2X7R on the other hand showed a decrease in the protein level to 68%, but rose with increasing cnSi nearly up to the control again (Fig. 6A).

Influence of macrophages on PCLS and the cell line E10

The lung interfaces with blood and air and is therefore exposed to a vast array of inhaled antigens and particulate matter and thus endangered of e.g. infections. To protect the organism from microbiological invasion the lung has a very high concentration of alveolar macrophages. Our present in vitro PCLS model lacks residual alveolar macrophages and other inflammatory cells of the circulation due to the artificial explant conditions.

To investigate the influence of macrophages we used a co-culture with AMJ2-C11 both in the cell culture with E10 and in the PCLS. The comparison of the PCLS experiments (with or without macrophages) showed some differences:

Apoptosis was lower with macrophages, indicated by a weaker increase of Cc3 (Fig. 1A).

Collagen deposition, as indicated by Sirius Red staining, was on the same level as without macrophages (Fig. 1C).

The increase of the Cav-1 protein level was by 20% weaker with macrophages than without (Fig. 3A), whereas T1α, Cav-2 and PKC-β1 showed a similar increase in the protein content (Fig. 2B, 4A and 5A). The protein content of P2X7R was at the same level as in the PCLS without macrophages (Fig. 6B).

The co-culture of the cell line E10 with macrophages revealed some major changes in the protein levels. T1α showed an increase of protein content to 150–200%, but stagnated at 200 μg/cm2 nano-silica with 210% (Fig. 2B). The amount of Cav-1 was reduced to 89% with a little increasing at higher cnSi up to 101% (Fig. 3B). Cav-2 was on the protein level of the control with all concentrations of nano-silica (Fig. 4B). The protein content of PKC-β1 increased to 103% at a concentration of 100 μg/cm2 nano-silica and to 117% at 200 μg/cm2 (Fig. 5B). The last protein, P2X7R, oscillated around the level of the control (Fig. 6B).

Differences in the induction of lung inflammation between wild type mice and P2rx7−/−mice

In this experiment we evaluated the influence of the P2X7R in the early phase of inflammation. For this purpose we used P2rx7−/−mice in comparison to wild type mice.

Similar to the above described method we assessed the changes in the protein content of Cav-1, Cav-2, T1α and PKC-β1 with and without macrophages.

Immunohistochemical staining of Cc3 showed a little increase of apoptosis after lung slice incubation with 1600 µg/ml nano-silica (Fig. 7A). We found no change in collagen deposition with Sirius Red staining (B).

Figure 7. Evaluation of cell damage by nano-silica and macrophages in the PCLS of P2rx7−/− mice.

Figure 7

Immunohistochemical staining of Cc3 (A) and Sirius Red staining (B) of untreated lung slices, slices treated with 1600 µg/ml silica and slices treated with 1600 µg/ml silica and co-cultured with AMJ2-C11 macrophages after 72 hours incubation. Scale bar = 50 µm.

The protein levels of Cav-1 and Cav-2 were significantly decreased to 78% and 87% respectively after 72 hours incubation with 1600 µg/ml nano-silica without macrophages. PKC-β1 also decreased to 81%, whereas T1α showed an increase to 112% (Fig. 8). With macrophages all protein levels are decreased ranging from 98% for T1α down to 79% for PKC-β1 (Fig. 8).

Figure 8. Immunohistochemical staining and protein content of Cav-1 (A), Cav-2 (B), T1α (C) and PKC-β1 (D) of untreated lung slices, slices treated with 1600 µg/ml silica and slices treated with 1600 µg/ml silica and co-cultured with AMJ2-C11 macrophages after 72 hours incubation.

Figure 8

γ-Tub is the loading control, n = 6–7. Scale bar = 50 µm.

Secretion of TNF-α and IL-6 in the PCLS of wild type and P2rx7−/− mice

We used for our experiments AMJ2-C11 macrophages, which secrete substantial amounts of IL-6 under stimulation with LPS, but not TNF-α [36]. To evaluate the influence of the macrophage produced IL-6, we measured the content of IL-6 and also the content of TNF-α in the supernatant of the PCLS after one, three and five days. We collected the supernatant of the PCLS of wild type and P2rx7−/− mice, each with and without macrophages as described under “Precision-cut lung slices and tissue culture”. The amount of IL-6 was significantly decreased in the supernatants of slices incubated with silica after one and three days compared to the controls. Remarkably addition of macrophages increased this effect. After five days the synthesis of IL-6 was restored and no differences could be detected compared to the controls. Similar effects were observed in P2rx7−/− mice (Fig. 9). However there is a difference between wild type and P2rx7−/− mice regarding the IL-6 content in the supernatant in the comparison of slices with and without macrophages after one day. In the wild type mice the addition of macrophages increased the effect of silica on the level of IL-6 whereas in the P2rx7−/− mice the macrophages had no further increasing effect.

Figure 9. Measurement of IL-6 (A, D), TNF-α (B, E) and IL-1β (C, F) in the supernatant of the PCLS via ELISA.

Figure 9

Compared are wild type (wt) and P2rx7−/− (ko) mice that were cultivated with and without (w/o) AMJ2-C11 macrophages with a nano-silica concentration of 1600 µg/ml. Data is presented in relation to the controls. The incubation time was 72 hours. n = 6–9.

The supernatant of slices incubated with silica showed an increase of TNF-α in wild type mice as well as in P2rx7−/− mice compared to the controls after one day. The addition of macrophages decreased this effect (Fig. 9). After three days no effect of silica or silica together with macrophages could be observed in both groups compared to the controls. Incubation with silica had also no effects on the level of TNF-α in both groups after five days whereas addition of macrophages moderately decreased the amount of TNF-α in the P2rx7−/− mice (Fig. 9).

The effects of silica and macrophages on the levels of IL-1β are quite similar to the effects on the amounts of TNF-α in wild type and in P2rx7−/− mice (Fig. 9).

Uptake of nano-silica by AMJ2-C11

One explanation of the influence of macrophages on the development and ongoing of early lung inflammation and pulmonary fibrosis is their phagocytosis of silica particles [45]. Once inside the particles seem to kill the macrophages by generation of reactive oxygen species [9].

To assess the time course of cell death after interaction with nano-silica we used a calcein / Annexin-V staining for flow cytometry analyses. We incubated the AMJ2-C11 with 1600 µg/ml nano-silica for 30 minutes, 24 hours, 48 hours and 72 hours. Independently of the point in time the controls showed approximately 90% living cells, whereas the macrophages incubated with silica showed a decreasing percentage of living cells. After 30 minutes incubation with silica vitality decreased to 72% and after 3 days the vitality was at 23% (Fig. 10).

Figure 10. FACS analysis on the viability of AMJ2-C11 macrophages incubated with 1600 µg/ml nano-silica.

Figure 10

The incubation times are 30 minutes, 24 hours, 48 hours and 72 hours. Data is presented in relation to the controls of each time point. n = 3.

Discussion

Silica is well known to induce oxidative stress and to be responsible for the release of inflammatory mediators leading in many cases to the development of fibrotic respiratory diseases [19]. There is evidence that the inhalation of such substances can induce the formation of the inflammosome complex, which involves the activation of caspase-1 and the release of proinflammatory cytokines IL-1β and IL-18 [46]. The involvement of purinergic signaling via P2X7 receptor in macrophages exposed to silica nanoparticles has been demonstrated by [47].

The current in vitro PCLS model revealed several differences to experimental animal models of chronic injury, where during the course of disease, for example in pulmonary fibrosis, a number of AEC I specific proteins are strongly diminished: T1α [48], ICAM-1 [49], aquaporin-5 [50], RAGE [51] and Cav-1 [52].

First, the exposure of immortal AEC I—like E10 cells as well as of PCLS to nano-silica particles induced an early increase of T1α, Cav-1 and -2, as well as PKC-ß1 within 72 hours. Similar in vitro induction of Cav-1 and T1α was obtained in vitro after exposure of alveolar epithelial cells to bleomycin [40]. The reason for this apparent discrepancy is not yet clear. Data from early time points of protein expression in alveolar epithelial cells of animal models after exposure with toxic and other agents are missing.

Second, the co-culture of lung slices with an immortal cell line maintaining properties of alveolar macrophages revealed unexpected alterations in the level of expression of acute lung cell markers in both directions: up- and downregulation. From these data we suggest that the co-culture of inflammatory cells with PCLS may provide a new tool for the study of the contribution of the systemic aspect (e.g. circulating inflammatory and immune cells) and its relationship to the resident cells of the lung parenchyma during inflammatory and other pathologic conditions.

Third, the comparison of the induction of lung inflammation in wild type mice showed an increased protein level of Cav-1 and -2 in contrast to the decreased protein levels of Cav-1 and -2 in P2rx7−/− mice. Nano-silica particles induced an inflammatory response such as increase of TNF-a and Il-1β after one day in wild type and P2rx7−/− mice. This response disappeared after prolonged incubation for three and five days. This resembles to a stress response like process.

P2rx7−/− mice showed a slight decreased Cav-1 and Cav -2 protein content. These effects have to be discussed in terms of the strong functional interaction of P2X7R isoforms with Cav-1 in caveolae, microdomains of AEC I. Previous studies of P2rx7−/− mice have shown a decreased Cav-1 protein level in lung epithelial type I cells [53]. Also Cav-1 downregulation in the E10 cell line resulted in a decreased P2X7R protein level [53].

These effects are unchanged in the presence of alveolar macrophages. These macrophages may contribute to early lung damage because of their secretion of pro-inflammatory substances like IL-6 [54]. Induction of cytokine release seems to depend on a damaging agent like silica or LPS and cell-cell interactions. [14] showed in a macrophage mono-culture after 24 hours incubation with nano-silica no significant release of IL-6 and IL-8, but high amounts in a co-culture with an alveolar epithelial cell line. Our macrophage cell line failed to produce higher levels of IL-6, TNF-a and IL-1β. Maybe this was due to a very high silica concentration that killed most macrophages as shown in our FACS experiment with the same nano-silica concentration as used in the PCLS experiments. Beside their potential pro-inflammatory effects, macrophages play a critical role for the pulmonary clearance like the transport of particulate reagents e.g. silica outside the alveoli and thus reducing the silica lung burden. In macrophages which phagocytosed nano-silica, agglomerated silica particles can be detected around the nucleus [14]. After intratracheal instillation of nano-silica these macrophages are primarily residing within airways and alveoli, but at subsequent times they can be found in the peribronchial, perivascular, interstitial, and subpleural connective tissues [55]. Together with our findings, that nano-silica phagocytosing macrophages are heavily damaged but still produce inflammatory mediators, we suggest that their migration into the interstitium is a central part for interstitial damage possibly leading to subsequent misrepair.

Acknowledgments

We acknowledge K. Pehlke, A. Neisser and S. Bramke for excellent technical help.

Data Availability

All relevant data are within the paper.

Funding Statement

The authors have no support or funding to report.

References

  • 1. Antonini JM, Roberts JR, Yang HM, Barger MW, Ramsey D, et al. (2000) Effect of silica inhalation on the pulmonary clearance of a bacterial pathogen in Fischer 344 rats. Lung 178: 341–350. 10.1007/s004080000038 [DOI] [PubMed] [Google Scholar]
  • 2. Fujimura N (2000) Pathology and pathophysiology of pneumoconiosis. Curr Opin Pulm Med 6: 140–144. 10.1097/00063198-200003000-00010 [DOI] [PubMed] [Google Scholar]
  • 3. Huaux F (2007) New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 7: 168–173. 10.1097/ACI.0b013e32802bf8a5 [DOI] [PubMed] [Google Scholar]
  • 4. Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel AB (1995) Cytokines and cytokine network in silicosis and coal workers’ pneumoconiosis. Eur Respir J 8: 834–842. [PubMed] [Google Scholar]
  • 5. Li XY, Brown D, Smith S, MacNee W, Donaldson K (1999) Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. Inhal Toxicol 11: 709–731. 10.1080/089583799196826 [DOI] [PubMed] [Google Scholar]
  • 6. Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B (2003) Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 186: 38–45. 10.1016/S0041-008X(02)00024-8 [DOI] [PubMed] [Google Scholar]
  • 7. Zhang Q, Kusaka Y, Zhu X, Sato K, Mo Y, et al. (2003) Comparative toxicity of standard nickel and ultrafine nickel in lung after intratracheal instillation. J Occup Health 45: 23–30. 10.1539/joh.45.23 [DOI] [PubMed] [Google Scholar]
  • 8. Chen M, von Mikecz A (2005) Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res 305: 51–62. 10.1016/j.yexcr.2004.12.021 [DOI] [PubMed] [Google Scholar]
  • 9. Eom HJ, Choi J (2009) Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B. Toxicol In Vitro 23: 1326–1332. 10.1016/j.tiv.2009.07.010 [DOI] [PubMed] [Google Scholar]
  • 10. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, et al. (2010) Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 65: 199–201. [PubMed] [Google Scholar]
  • 11. Shi Y, Yadav S, Wang F, Wang H (2010) Endotoxin promotes adverse effects of amorphous silica nanoparticles on lung epithelial cells in vitro. J Toxicol Environ Health A 73: 748–756. 10.1080/15287391003614042 [DOI] [PubMed] [Google Scholar]
  • 12. Ye Y, Liu J, Chen M, Sun L, Lan M (2010) In vitro toxicity of silica nanoparticles in myocardial cells. Environ Toxicol Pharmacol 29: 131–137. 10.1016/j.etap.2009.12.002 [DOI] [PubMed] [Google Scholar]
  • 13. Lin W, Huang YW, Zhou XD, Ma Y (2006) In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 217: 252–259. 10.1016/j.taap.2006.10.004 [DOI] [PubMed] [Google Scholar]
  • 14. Wottrich R, Diabate S, Krug HF (2004) Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health 207: 353–361. 10.1078/1438-4639-00300 [DOI] [PubMed] [Google Scholar]
  • 15. Ye Y, Liu J, Xu J, Sun L, Chen M, et al. (2010) Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol In Vitro 24: 751–758. 10.1016/j.tiv.2010.01.001 [DOI] [PubMed] [Google Scholar]
  • 16. Yu K, Grabinski C, Schrand A, Murdock R, Wang W, et al. (2009) Toxicity of amorphous silica nanoparticles in mouse keratinocytes. Journal of Nanoparticle Research 11: 15–24. 10.1007/s11051-008-9417-9 [DOI] [Google Scholar]
  • 17. Herold S, Gabrielli NM, Vadasz I (2013) Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 305: L665–681. 10.1152/ajplung.00232.2013 [DOI] [PubMed] [Google Scholar]
  • 18. Wilson MS, Wynn TA (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2: 103–121. 10.1038/mi.2008.85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Moore BB, Hogaboam CM (2008) Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152–160. 10.1152/ajplung.00313.2007 [DOI] [PubMed] [Google Scholar]
  • 20. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, et al. (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279: 51630–51646. 10.1074/jbc.M409214200 [DOI] [PubMed] [Google Scholar]
  • 21. Jin Y, Lee SJ, Minshall RD, Choi AM (2011) Caveolin-1: a critical regulator of lung injury. Am J Physiol Lung Cell Mol Physiol 300: L151–160. 10.1152/ajplung.00170.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Jin Y, Kim HP, Chi M, Ifedigbo E, Ryter SW, et al. (2008) Deletion of caveolin-1 protects against oxidative lung injury via up-regulation of heme oxygenase-1. Am J Respir Cell Mol Biol 39: 171–179. 10.1165/rcmb.2007-0323OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Jin Y, Kim HP, Cao J, Zhang M, Ifedigbo E, et al. (2009) Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death. Faseb j 23: 341–350. 10.1096/fj.08-108423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Zhang M, Lin L, Lee SJ, Mo L, Cao J, et al. (2009) Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways. Am J Physiol Lung Cell Mol Physiol 297: L945–953. 10.1152/ajplung.00081.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kasper M, Barth K (2009) Bleomycin and its role in inducing apoptosis and senescence in lung cells—modulating effects of caveolin-1. Curr Cancer Drug Targets 9: 341–353. 10.2174/156800909788166501 [DOI] [PubMed] [Google Scholar]
  • 26. Mungunsukh O, Griffin AJ, Lee YH, Day RM (2010) Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 298: L696–703. 10.1152/ajplung.00322.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Odajima N, Betsuyaku T, Nasuhara Y, Nishimura M (2007) Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem 55: 899–909. 10.1369/jhc.7A7203.2007 [DOI] [PubMed] [Google Scholar]
  • 28. Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, et al. (2006) Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 290: L790–l796. 10.1152/ajplung.00300.2004 [DOI] [PubMed] [Google Scholar]
  • 29. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, et al. (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895–2906. 10.1084/jem.20061536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Barth K, Weinhold K, Guenther A, Linge A, Gereke M, et al. (2008) Characterization of the molecular interaction between caveolin-1 and the P2X receptors 4 and 7 in E10 mouse lung alveolar epithelial cells. Int J Biochem Cell Biol 40: 2230–2239. 10.1016/j.biocel.2008.03.001 [DOI] [PubMed] [Google Scholar]
  • 31. Riteau N, Baron L, Villeret B, Guillou N, Savigny F, et al. (2012) ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis 3: e403 10.1038/cddis.2012.144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Moncao-Ribeiro LC, Faffe DS, Santana PT, Vieira FS, da Graca CL, et al. (2014) P2X7 receptor modulates inflammatory and functional pulmonary changes induced by silica. PLoS One 9: e110185 10.1371/journal.pone.0110185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Wiley JS, Gu BJ (2012) A new role for the P2X7 receptor: a scavenger receptor for bacteria and apoptotic cells in the absence of serum and extracellular ATP. Purinergic Signal 8: 579–586. 10.1007/s11302-012-9308-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, et al. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125–132. 10.1074/jbc.M006781200 [DOI] [PubMed] [Google Scholar]
  • 35. Herzog CR, Soloff EV, McDoniels AL, Tyson FL, Malkinson AM, et al. (1996) Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene 13: 1885–1891. [PubMed] [Google Scholar]
  • 36. Palleroni AV, Varesio L, Wright RB, Brunda MJ (1991) Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines. Int J Cancer 49: 296–302. 10.1002/ijc.2910490226 [DOI] [PubMed] [Google Scholar]
  • 37. Held HD, Martin C, Uhlig S (1999) Characterization of airway and vascular responses in murine lungs. Br J Pharmacol 126: 1191–1199. 10.1038/sj.bjp.0702394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Ebeling G, Blasche R, Hofmann F, Augstein A, Kasper M, et al. (2014) Effect of P2X7 Receptor Knockout on AQP-5 Expression of Type I Alveolar Epithelial Cells. PLoS One 9: e100282 10.1371/journal.pone.0100282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Dieckmann-Schuppert A, Schnittler HJ (1997) A simple assay for quantification of protein in tissue sections, cell cultures, and cell homogenates, and of protein immobilized on solid surfaces. Cell Tissue Res 288: 119–126. 10.1007/s004410050799 [DOI] [PubMed] [Google Scholar]
  • 40. Linge A, Morishima N, Kasper M, Barth K (2007) Bleomycin induces caveolin-1 and -2 expression in epithelial lung cancer A549 cells. Anticancer Res 27: 1343–1351. [PubMed] [Google Scholar]
  • 41. Kasper M, Seidel D, Knels L, Morishima N, Neisser A, et al. (2004) Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1. Histochem Cell Biol 121: 131–140. 10.1007/s00418-003-0612-6 [DOI] [PubMed] [Google Scholar]
  • 42. Kasper M, Fehrenbach H (2000) Immunohistochemical evidence for the occurrence of similar epithelial phenotypes during lung development and radiation-induced fibrogenesis. Int J Radiat Biol 76: 493–501. 10.1080/095530000138493 [DOI] [PubMed] [Google Scholar]
  • 43. McElroy MC, Kasper M (2004) The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 24: 664–673. 10.1183/09031936.04.00096003 [DOI] [PubMed] [Google Scholar]
  • 44. Bläsche R, Ebeling G, Perike S, Weinhold K, Kasper M, et al. (2012) Activation of P2X7R and downstream effects in bleomycin treated lung epithelial cells. Int J Biochem Cell Biol 44: 514–524. 10.1016/j.biocel.2011.12.003 [DOI] [PubMed] [Google Scholar]
  • 45. Gilberti RM, Joshi GN, Knecht DA (2008) The phagocytosis of crystalline silica particles by macrophages. Am J Respir Cell Mol Biol 39: 619–627. 10.1165/rcmb.2008-0046OC [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Rastrick J, Birrell M (2014) The role of the inflammasome in fibrotic respiratory diseases. Minerva Med 105: 9–23. [PubMed] [Google Scholar]
  • 47. Kojima S, Negishi Y, Tsukimoto M, Takenouchi T, Kitani H, et al. (2014) Purinergic signaling via P2X7 receptor mediates IL-1beta production in Kupffer cells exposed to silica nanoparticle. Toxicology 321: 13–20. 10.1016/j.tox.2014.03.008 [DOI] [PubMed] [Google Scholar]
  • 48. Koslowski R, Dobbs LG, Wenzel KW, Schuh D, Muller M, et al. (1998) Loss of immunoreactivity for RTI40, a type I cell-specific protein in the alveolar epithelium of rat lungs with bleomycin-induced fibrosis. Eur Respir J 12: 1397–1403. 10.1183/09031936.98.12061397 [DOI] [PubMed] [Google Scholar]
  • 49. Kasper M, Koslowski R, Luther T, Schuh D, Muller M, et al. (1995) Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis. Histochem Cell Biol 104: 397–405. 10.1007/BF01458134 [DOI] [PubMed] [Google Scholar]
  • 50. Gabazza EC, Kasper M, Ohta K, Keane M, D’Alessandro-Gabazza C, et al. (2004) Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse. Pathol Int 54: 774–780. 10.1111/j.1440-1827.2004.01754.x [DOI] [PubMed] [Google Scholar]
  • 51. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, et al. (2008) A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 172: 583–591. 10.2353/ajpath.2008.070569 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Kasper M, Reimann T, Hempel U, Wenzel KW, Bierhaus A, et al. (1998) Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol 109: 41–48. 10.1007/s004180050200 [DOI] [PubMed] [Google Scholar]
  • 53. Barth K, Weinhold K, Guenther A, Young MT, Schnittler H, et al. (2007) Caveolin-1 influences P2X7 receptor expression and localization in mouse lung alveolar epithelial cells. Febs j 274: 3021–3033. 10.1111/j.1742-4658.2007.05830.x [DOI] [PubMed] [Google Scholar]
  • 54. Rao KM, Porter DW, Meighan T, Castranova V (2004) The sources of inflammatory mediators in the lung after silica exposure. Environ Health Perspect 112: 1679–1686. 10.1289/ehp.7295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Green FH, Vallyathan V, Hahn FF (2007) Comparative pathology of environmental lung disease: an overview. Toxicol Pathol 35: 136–147. 10.1080/01926230601132055 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES